BANK OF AMERICA CORP /DE/ - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$4,323
-23.9%
3,0880.0%0.00%
Q2 2023$5,682
-24.3%
3,0880.0%0.00%
Q1 2023$7,504
+67.6%
3,088
-1.4%
0.00%
Q4 2022$4,477
-65.6%
3,131
-48.1%
0.00%
Q3 2022$13,000
+8.3%
6,0290.0%0.00%
Q2 2022$12,000
-29.4%
6,0290.0%0.00%
Q1 2022$17,000
-26.1%
6,029
-14.4%
0.00%
Q4 2021$23,000
-74.7%
7,046
-72.6%
0.00%
Q3 2021$91,000
-42.8%
25,696
-48.7%
0.00%
Q2 2021$159,000
-8.6%
50,068
-1.6%
0.00%
Q1 2021$174,000
+397.1%
50,862
+263.2%
0.00%
Q4 2020$35,000
+483.3%
14,003
+396.4%
0.00%
Q3 2020$6,000
-64.7%
2,821
-64.1%
0.00%
Q2 2020$17,000
+466.7%
7,855
+582.5%
0.00%
Q1 2020$3,000
-95.0%
1,151
-95.0%
0.00%
Q4 2019$60,000
-31.0%
23,130
-3.3%
0.00%
Q3 2019$87,000
+47.5%
23,925
+35.5%
0.00%
Q2 2019$59,000
-57.6%
17,652
-65.4%
0.00%
Q1 2019$139,000
-26.1%
51,071
-24.8%
0.00%
Q4 2018$188,000
+69.4%
67,911
+151.7%
0.00%
Q3 2018$111,000
-11.2%
26,982
+12.5%
0.00%
Q2 2018$125,000
-16.7%
23,985
-12.2%
0.00%
Q1 2018$150,000
-43.4%
27,318
-16.1%
0.00%
Q4 2017$265,000
-49.8%
32,550
-35.5%
0.00%
Q3 2017$528,000
+12.6%
50,443
+18.6%
0.00%
Q2 2017$469,000
+96.2%
42,525
+48.8%
0.00%
Q1 2017$239,000
+198.8%
28,585
+149.3%
0.00%
Q4 2016$80,000
+86.0%
11,467
+35.3%
0.00%
Q3 2016$43,000
+7.5%
8,478
+25.1%
0.00%
Q2 2016$40,000
-35.5%
6,779
-51.0%
0.00%
Q1 2016$62,000
-1.6%
13,830
-1.3%
0.00%
Q4 2015$63,000
+40.0%
14,0080.0%0.00%
Q3 2015$45,000
-2.2%
14,008
-6.3%
0.00%
Q2 2015$46,000
+9.5%
14,952
+6.0%
0.00%
Q1 2015$42,000
-42.5%
14,103
-14.0%
0.00%
Q4 2014$73,000
+62.2%
16,408
+88.6%
0.00%
Q3 2014$45,000
-73.1%
8,702
-72.7%
0.00%
Q2 2014$167,000
+5466.7%
31,835
+4219.5%
0.00%
Q1 2014$3,000
-25.0%
737
-41.9%
0.00%
Q4 2013$4,000
-81.8%
1,269
-85.3%
0.00%
Q3 2013$22,000
-4.3%
8,610
-19.9%
0.00%
Q2 2013$23,00010,7470.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders